Downloadable Slidesets

Share

Program Content

Activities

  • ICIs Across Lung Cancer
    The Why and Who: Overview of Immune Checkpoint Blockade in Lung Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 05, 2019

    Expires: November 03, 2020

  • PD-L1 and Molecular Testing in Lung Cancer
    The How: Current Predictors of Response to Immune Checkpoint Inhibitors
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 05, 2019

    Expires: November 03, 2020

  • Emerging ICI Biomarkers
    The Future: Opportunities for Predictive Biomarkers for Cancer Immunotherapy
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 05, 2019

    Expires: November 03, 2020

Faculty

cover img faculity

Joshua Bauml, MD

Instructor, Division of Hematology/Oncology
Perelman School of Medicine at the University of Pennsylvania
Staff Physician
Philadelphia VA Medical Center
Philadelphia, Pennsylvania

cover img faculity

Hossein Borghaei, MS, DO

Associate Professor
Chief,
Thoracic Medical Oncology
Department of Hematology and Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

cover img faculity

Heather J. Jackson, PhD, FNP-BC, NEA-BC, FAANP

Associate Professor
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University School of Nursing
Administrative Director of Advanced Practice
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

Sanjay Mukhopadhyay, MD

Director, Pulmonary Pathology
Department of Pathology
Cleveland Clinic
Cleveland, Ohio

cover img faculity

Sandip P. Patel, MD

Professor, Medical Oncology, UC San Diego
Leader, Experimental Therapeutics
Deputy Director, Sanford Stem Cell Clinical Center
Co-Leader, Solid Tumor Therapeutics Program
Medical Director, Clinical Research Informatics
La Jolla, California

Provided by

ProCE Banner

Supporters

AstraZeneca

Bristol Myers Squibb

Genentech TEXT Only

Merck Sharp & Dohme Corp.